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Objectives: To assess the prevalence of vitiligo among patients with dermatological diseases in Najran, South-Western Saudi Arabia,
and to explore the epidemiological proﬁle of vitiligo patients in the region.
Materials and methods: This single-observer, cross-sectional, descriptive study was conducted over a period of six months by record-
ing the clinico-epidemiological proﬁle of 101 vitiligo cases. The patients were diagnosed by history, clinical ﬁndings and Wood’s lamp at
the dermatology out-patient clinic in the King Khalid Hospital, Najran. Demographic and clinical data of the patients were collected
using a pre-structured data collection form. Pearson v2 test and Fisher’s exact test were used to explore the signiﬁcant association of
selected characteristics with ‘type’ and ‘site’ of vitiligo among the study-patients.
Results: The estimated prevalence of vitiligo cases among the dermatology out-patient clinic attendees was 1.98%. Vitiligo patients
were predominantly males (57.4%), Saudis (93.1%), housewives (24.8%), and non-smokers (95%). The mean age of the study-patients
was 34.33 ± 15.82 years, and the highest number (28.7%) belonged to the age group ‘31–40 years’. Of the cases, 5.9% had a family history
of vitiligo, 6.9% had diabetes mellitus, and 4% were suﬀering from anemia. Approximately 99% of the patients or the parents of the pedi-
atric patients were aﬀected by either moderate or mild stress due to vitiligo. Highest number (48.5%) of the patients presented localized
type of vitiligo, whereas 22.8% had acrofacial, 20.8% showed vulgaris, 5% presented universal, 2% had acral, and 1% experienced seg-
mental type of vitiligo. Around one-fourth (25.7%) of the patients had vitiligo only on their extremities, while remaining cases experi-
enced vitiligo on the other parts of their body. Median duration of the disease was 4 years (IQR: 2–7.5 years). The type of vitiligo
showed a signiﬁcant association with sex, underlying diseases, and stress grade (p < 0.05), while the site of vitiligo was signiﬁcantly asso-
ciated with sex and stress grade (p < 0.05).
Conclusion: Localized vitiligo was found to be the most common type of vitiligo prevalent in the Najran Region. Because stress has a
role in provoking vitiligo, community based awareness programs should be developed to reduce the stress in order to control and modify
the course of the disease.
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Vitiligo is a hypo-pigmentation disorder of the skin and
hair characterized by well-circumscribed, asymptomatic
white cutaneous macule aﬀecting 0.1–4% of the population
worldwide in all races and both sexes (Steiner et al., 2004).
Based on the size and distribution of the depigmented area,
vitiligo is classiﬁed into localized, generalized and universalSaud University.
commons.org/licenses/by-nc-nd/3.0/).
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tion of the skin and/or mucous membranes (Kovacs, 1998;
Sehgal and Srivastava, 2007; Alkhateeb et al., 2003).
The exact etiology of vitiligo is not fully understood.
There are principle theories presented about the mecha-
nism of destruction of melanocytes including autoimmune
theory, neurogenic theory and self-destructive theory
(Forschner et al., 2007). Many studies suggest that vitiligo
can be considered as an autoimmune disease and it has fre-
quently been described in association with other autoim-
mune diseases including thyroid disorders, diabetes
mellitus, alopecia areata, pernicious anemia, systemic lupus
erythematosus (SLE), rheumatoid arthritis (RA), autoim-
mune polyglandular syndrome, and psoriasis (Laberge
et al., 2005; Zettinig et al., 2003).
The actual onset of vitiligo in genetically suspected indi-
viduals seems to require exposure to environmental triggers
such as trauma and sun exposure (Steiner et al., 2004). Vit-
iligo has a genetic background. More than 30% of the
aﬀected individuals have reported vitiligo in a parent, sib-
ling, and it is reported in identical twins. Theoretically,
consanguineous marriages should carry a high risk for
the development of diseases that have a genetic basis, either
completely or partially (Khoury et al., 1987; Freire-Maia,
1990). In a previous Saudi study (Alzolibani, 2009) in the
Qassim region, one-third of all cases (22.5%) were positive
for a parental consanguinity with a particularly high ﬁrst-
cousin consanguinity that was higher than that reported
(19.5%) among the general Saudi population (el-Hazmi
et al., 1995).
Currently in the literature, there is a paucity of studies
that demonstrate the epidemiological proﬁle of vitiligo
among Saudi population with no previous reports from
the Najran Region, southwestern Saudi Arabia. This study
was aimed to assess the prevalence of vitiligo among the
patients with dermatological diseases in Najran, South-
Western Saudi Arabia and to describe the epidemiological
proﬁle of vitiligo patients.
2. Materials and methods
2.1. Study design, place and time
We conducted a single-observer, cross-sectional,
descriptive study over a period of six months by recording
the clinico-epidemiological proﬁle of 101 vitiligo cases. The
patients were diagnosed at the dermatology out-patient
clinic in the King Khalid Hospital Najran, Saudi Arabia
during the period from January 2012 to July 2012.
2.2. Clinical assessment of cases
Full patient’s history was taken from each case as well as
clinical examination was performed. Vitiligo cases were
diagnosed by history, clinical ﬁndings and Wood’s lamp.
A complete blood count, routine biochemistry tests and
thyroid hormones were also performed for each case.2.3. Data collection
Demographic and clinical data of the patients were col-
lected using a data collection form. Each patient’s age, sex,
occupational status, educational status, familial history of
vitiligo, duration of the disease, site/distribution of vitiligo
lesions, clinical type, coexisting systemic diseases (such as
diabetes mellitus, hypertension, thyroid disorder, perni-
cious anemia, arthritis etc.) and other associated dermato-
logical conditions (such as psoriasis, atopic dermatitis,
alopecia areata etc.), self-perception about possible cause
of contracting vitiligo, and smoking status were recorded.
Moreover, histories of precipitating or initiating factors
like physical trauma, sun exposure, and emotional stress
were noted. Stress grade was labeled as: 0 = no signiﬁcant
stress, 1 = mild stress, 2 = moderate stress, 3 = sever stress.
2.4. Data analysis
All data were coded, validated, and then analyzed using
SPSS 16.0 for Windows (IBM Corporation, NY, USA).
Pearson v2 test and Fisher’s exact test were used to see
whether there is any signiﬁcant association of selected char-
acteristics with ‘type’ and ‘site’ of vitiligo among the study-
patients. P value less than 0.05 was accepted as the level of
statistical signiﬁcance. Fisher’s exact test was performed if
any expected frequency was less than 2 or if more than 20%
of the expected frequencies were less than 5.
3. Results
Of the total 5097 patients who visited the dermatology
outpatient department (OPD) during the study period,
101 individuals were diagnosed as vitiligo cases. Therefore,
the estimated prevalence of vitiligo cases among the derma-
tology OPD attendees was 1.98% during the speciﬁc period
of data collection.
Table 1 illustrates socio-demographic characteristics of
the vitiligo patients we studied. Among 101 patients,
majority (57.4%) were male, while remaining 42.6% were
female. Mean age of the study patients was
34.33 ± 15.82 years with a range from 4 to 75 years. Of
the patients, highest number (28.7%) belonged to the age
group 31–40 years, while 15.8% of them were below
18 years, and 13.9% were 51 years old or more. The
patients were predominantly Saudis (93.1%), whereas a
few (6.9%) were from other nationalities. Among the
respondents, 27.7% had no formal education, 15.8%
received primary education, 25.7% completed secondary
education, and the remaining individuals (30.7%) had a
higher level of education. Regarding occupational status,
maximum (24.8%) respondents were housewives, followed
by students (16.8%), government service holders (15.8%),
armed forces job holders (12.9%), teachers (7.9%), and so
on (Table 1).
Table 2 shows the history and clinical proﬁle of the vit-
iligo patients. Of the cases, 5.9% had a family history of vit-
Table 1
Socio-demographic characteristics of patients (n = 101) with vitiligo,
Najran Region, Saudi Arabia, 2013.
Socio-demographic characteristics Frequency (%)
Sex
Male 58 (57.4)
Female 43 (42.6)
Age* group
<18 years 16 (15.8)
18–30 years 20 (19.8)
31–40 years 29 (28.7)
41–50 years 22 (21.8)
P51 years 14 (13.9)
Nationality
Saudi 94 (93.1)
Non-Saudi 7 (6.9)
Educational status
No education 28 (27.7)
Primary 16 (15.8)
Secondary 26 (25.7)
Higher diploma 2 (2.0)
Intermediate 4 (4.0)
Bachelor 16 (15.8)
Master 6 (5.9)
University student 3 (3.0)
Occupational status
Housewife 25 (24.8)
Student 17 (16.8)
Government job 16 (15.8)
Armed Forces job 13 (12.9)
Teacher 8 (7.9)
Children under school age 6 (5.9)
Retired 6 (5.9)
Private job 4 (4.0)
Health care professional 4 (4.0)
Businessman 1 (1.0)
Unemployed 1 (1.0)
* Mean age: 34.33 ± 15.82 years; minimum age: 4 years; maximum age:
75 years.
Table 2
History and clinical proﬁle of patients (n = 101) with vitiligo, Najran
Region, Saudi Arabia, 2013.
Characteristics Frequency (%)
Family history of vitiligo
Yes 6 (5.9)
No 95 (94.1)
Underlying associated diseases
None 83 (82.2)
Diabetes mellitus 7 (6.9)
Anemia 4 (4.0)
Psoriasis 2 (2.0)
Physical deformity 2 (2.0)
Alopecia areata 1 (1.0)
Hypertension 1 (1.0)
Hypothyroidism 1 (1.0)
Smoking status
Non-smoker 96 (95.0)
Smoker 5 (5.0)
Stress grade
No signiﬁcant stress 1 (1.0)
Mild stress 34 (33.7)
Moderate stress 59 (58.4)
Severe stress 0 (0.0)
Stress on parents for pediatric patients 7 (6.9)
Self-perception about probable cause of contracting vitiligo
Unknown 68 (67.3)
Stress 17 (16.8)
Sun exposure 14 (13.9)
Kerosene exposure 2 (2.0)
Type of vitiligo
Localized 49 (48.5)
Acrofacial 23 (22.8)
Vulgaris 21 (20.8)
Universal 5 (5.0)
Acral 2 (2.0)
Segmental 1 (1.0)
Site of vitiligo during diagnosis
Extremities 26 (25.7)
Face, hand, and foot 23 (22.8)
Face and trunk 13 (12.9)
Face 10 (9.9)
Hands 10 (9.9)
Trunk 8 (7.9)
Face, trunk, and extremities 5 (5.0)
Whole body 5 (5.0)
Genitalia and forearms 1 (1.0)
Duration* of the disease
<10 years 87 (86.1)
11–20 years 10 (9.9)
P21 years 4 (4.0)
* Median duration: 4 years (IQR: 2–7.5 years); minimum: 1 year; maxi-
mum: 35 years.
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Majority (82.2%) of the respondents were not suﬀering
from any underlying diseases, whereas 6.9% had diabetes
mellitus, and 4% had anemia. Moreover, some other under-
lying diseases were reported such as psoriasis and physical
deformities each in 2%, and alopecia areata, hypertension
and hypothyroidism each in 1% of the study patients.
Regarding smoking status our study revealed that most
(95%) of the patients were non-smokers, while only 5% of
them were smokers. Almost 99% of the vitiligo patients
or their parents (of pediatric patients) were found to be
aﬀected by mental stress. Moderate stress was reported
among majority (58.4%) of the patients, while 33.7% of
them were aﬀected by mild stress. Self-perception among
the patients or their guardians about the probable cause
of contracting vitiligo was ‘unknown’ for 67.3% cases,
‘stress’ for 16.8% cases, ‘sun exposure’ for 13.9% of cases,
and ‘kerosene exposure’ for 2% cases. Of the total 101
patients, highest number (48.5%) presented localized type
of vitiligo, whereas 22.8% had acrofacial, 20.8% showedvulgaris, 5% presented universal, 2% had acral, and 1%
experienced segmental type of vitiligo. Regarding the site
of vitiligo, around one-fourth (25.7%) of the patients had
vitiligo only on their extremities, while remaining cases
experienced vitiligo on other parts of their body (Table 1).
Regarding the duration of the disease, 86.1% respondents
informed that they were having vitiligo for less than
Table 3
Association of selected characteristics with type and site of vitiligo among
study-patients (n = 101), Najran Region, Saudi Arabia, 2013.
Characteristics Association with
type of vitiligo
[p value*]
Association with
site of vitiligo
[p value*]
Sex 0.026 0.004
Nationality 0.531 0.680
Family history 0.610 0.562
Underlying associated diseases 0.030 0.055
Smoking status 0.416 0.693
Stress grade 0.049 0.048
* Determined by the Pearson v2 or Fisher’s exact test. Fisher’s exact test
was performed if any expected frequency was less than 2 or if more than
20% of the expected frequencies were less than 5.
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ease for ‘11–20 years’ and ‘21 years or more’, respectively.
Median duration of the disease was 4 years (IQR: 2–7.5
years) with a minimum duration of 1 year and a maximum
duration of 35 years.
Pearson v2 test and Fisher’s exact test results revealed
whether there is any signiﬁcant association of selected char-
acteristics with ‘type’ and ‘site’ of vitiligo among the study-
patients (Table 3). The type of vitiligo was in signiﬁcant
association with sex, underlying diseases, and stress grade
(p < 0.05), while the site of vitiligo was signiﬁcantly associ-
ated with sex and stress grade (p < 0.05).4. Discussion
In the present study, we found 1.98% prevalence of vit-
iligo among the attendees of dermatology OPD, which is
consistent with the previous studies carried out in Al Baha
(Somorin and Krahn, 1997) and Riyadh (Jarallah et al.,
1993) showing a prevalence of 2.7% and 2.5% respectively,
but higher than the prevalence (0.43%) observed in the
study conducted in Makkah (Fatani et al., 2014). Our
study showed a male predominance (57.4%) among the vit-
iligo patients, which is almost similar to the study result
observed in the King Khalid University Hospital
(Jarallah et al., 1993), while a number of other study
reports (Somorin and Krahn, 1997; Fatani et al., 2014;
Alissa, 2011) within the Kingdom showed a higher occur-
rence of vitiligo among the female individuals.
Our study showed a mean age of 34.33 years for the vit-
iligo patients, which is nearly in agreement with the other
investigations which reported a mean age ranging from
24.5 to 34 years (Alzolibani, 2009; Somorin and Krahn,
1997; Jarallah et al., 1993; Fatani et al., 2014; Al Robaee,
2007; AlGhamdi, 2010). According to our study, the indi-
viduals belonging to adult age groups were aﬀected more
than the younger individuals (Table 1). A similar result
was found in the study conducted in the National Center
for Vitiligo and Psoriasis, Saudi Arabia (Al-Mubarak
et al., 2011), although other reports indicated children
and adolescents as more suﬀered groups (Jarallah et al.,1993; Fatani et al., 2014). Saudis were predominant
(>93%) among the vitiligo patients compared to non-Saudi
nationals as revealed in our study, and also in other similar
studies (Somorin and Krahn, 1997; Jarallah et al., 1993).
Only 5.9% patients had a positive family history of vit-
iligo in the present study, while the same history was found
positive among a comparatively higher number of patients
in other studies (Alzolibani, 2009; Somorin and Krahn,
1997; Jarallah et al., 1993; Fatani et al., 2014; Alissa,
2011). Similar to our study ﬁndings, diabetes mellitus
(Somorin and Krahn, 1997; Fatani et al., 2014; Alissa,
2011), psoriasis (Fatani et al., 2014; Alissa, 2011), alopecia
areata (Fatani et al., 2014; Alissa, 2011), anemia (Alissa,
2011), hypothyroidism (Alissa, 2011), and hypertension
(Alissa, 2011) were also reported as underlying associated
diseases among the vitiligo patients in respective previous
studies. Majority of our study patients did not presume
any cause for having vitiligo which is consistent with the
study conducted in the National Center for Vitiligo and
Psoriasis, Saudi Arabia (Alissa, 2011). However, ‘stress’
was considered a cause of contracting vitiligo by 16.8%
of the cases in our study, while ‘stress and fear’ were con-
sidered a cause by 26.8% of the patients in the study con-
ducted by Alissa (2011).
Median duration of the disease among the vitiligo
patients was 4 years in the present study, which is relatively
lower than the mean durations, 6.89 and 7.9 years,
reported from Qassim (Alzolibani, 2009) and Central Saudi
Arabia (Alissa, 2011), respectively. Among diﬀerent types
of vitiligo (Table 2), the most common one we found in
our study was ‘localized’ type of vitiligo. This ﬁnding is
in agreement with the results of the study carried out by
Fatani et al., 2014 and Alzolibani (2009), although Alissa
et al. reported ‘vulgaris’ type of vitiligo as the most com-
mon type (Alissa, 2011). Regarding the site of vitiligo,
‘face’ was identiﬁed as the most commonly aﬀected site
among our study patients, which is consistent with the
study ﬁndings shown by Alissa (2011) On the contrary,
‘lower limbs’ were reported as the most common site for
vitiligo lesions in other studies (Somorin and Krahn,
1997; Fatani et al., 2014).
Our study is limited by the fact that we could not collect
data for all vitiligo patients who attended the skin OPD,
because a number of them did not come to us for follow-
up visits regularly due to the lack of awareness. Moreover,
some of the patients were not cooperative to perform all
required investigations. Time constraint for data collection
was another limitation.
The present study showed that the clinico-epidemiolog-
ical aspects of vitiligo in the Najran Region were nearly
similar to the results of other local studies conducted in
Saudi Arabia. Our study reﬂected that localized vitiligo
was the most common type of vitiligo prevalent in the Naj-
ran Region. This study identiﬁed ‘stress’ to be associated
with 99% of the vitiligo patients indicating that stress has
a role in provoking vitiligo, and there is a need to develop
community based awareness programs to reduce the stress
H.A. AL Fahaad / Journal of Dermatology & Dermatologic Surgery 19 (2015) 31–35 35at individual and family levels in order to control and mod-
ify the course of the disease.
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